BioCentury | Jul 11, 2016
Clinical News

AB001: Phase II data

...double-blind, U.S. Phase II trial in 146 patients with chronic lower back pain showed that AB001...
...pain relief as measured by a VAS from baseline to week 2 vs. placebo (p=0.023). AB001...
...at week 1 (p-0.035) and week 2 (p=0.045) vs. placebo. From baseline to week 2, AB001...
Items per page:
1 - 1 of 1